The Hidden Barriers to Clinical Adoption with Amel Havkic

Why do so many promising MedTech companies fail even when the technology is strong, the funding is there and the product is compliant?

In this episode of the Med Device Cyber Podcast, Christian Espinosa speaks with Amel Havkic, founder of EvoMed Consulting, about the hidden barriers that prevent medical technologies from achieving real clinical adoption.

Amel explains why clinical adoption is often treated too late, how workflow friction can derail an otherwise strong product and why the founder’s greatest strength can sometimes become the company’s biggest strategic blind spot.

The conversation also explores the KOL trap, the cost of forcing behavior change inside already overstretched clinical environments and why cybersecurity, reimbursement, usability and implementation cannot be treated as separate problems.

In This Episode

• 01:08 Amel Havkic and VivoMed Consulting

• 02:41 Why 75% of MedTech companies fail

• 04:43 Clinical adoption, fundability and founder blind spots

• 07:23 Why one solution must satisfy many stakeholders

• 09:42 Economic viability and implementation friction

• 12:37 The hidden cost of changing clinical behaviour

• 15:43 The KOL trap and why pilots can mislead

• 18:46 Alarm fatigue and real-world clinical environments

• 20:46 Christian’s introduction to medical-device cybersecurity

• 23:04 Why cybersecurity deficiencies derail submissions

• 27:49 Building the right team around a MedTech founder

• 32:38 Authenticity, intuition and choosing the right partners

• 37:17 Why being human may become a superpower in the age of AI